What does this test include?
This test measures CD13-positive cell counts in EDTA blood, performed with accuracy by Metropolis Healthcare.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses flow cytometry to detect and quantify CD13 expression on myeloid cells.
Who should take this test?
Patients suspected of having myeloid leukemias or abnormal blood cell proliferation can benefit at Metropolis Healthcare.
Why is CD13 testing important?
Metropolis Healthcare uses this test to assess myeloid lineage involvement and cellular maturation.
Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs an EDTA blood sample.
What do high CD13 counts indicate?
High counts at Metropolis Healthcare may suggest increased myeloid activity or leukemia.
What do low CD13 counts mean?
Low levels at Metropolis Healthcare can reflect reduced myeloid cell presence or bone marrow suppression.
How long does it take to get results?
Metropolis Healthcare provides timely and reliable results to support clinical evaluation.